Holding(s) in Company

Summary by AI BETAClose X

Spreadex LTD has notified CRISM Therapeutics Corporation of a change in its major holdings, with the threshold crossed on July 28, 2026. Following an acquisition or disposal of financial instruments, Spreadex LTD now holds a total of 3.536500% of the voting rights, comprising 2.525700% directly attached to shares and 1.010800% through financial instruments, specifically a CFD/Swap settled in cash. This represents an increase from their previous notification where they held 2.905000% of the voting rights.

Disclaimer*

UK 100

Latest directors dealings